HistoSonics is a privately held medical device company developing non-invasive platforms and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors.
Market
Healthcare
Location
Ann Arbor,
Michigan,
USA
Coinvestors
Alpha Wave Ventures, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation, Lumira Ventures, State of Wisconsin Investment Board, Yonjin Venture